AU Patent

AU2020250309B2 — Pharmaceutical compositions comprising sorbitan esters

Assigned to Alkermes Pharma Ireland Ltd · Expires 2022-08-04 · 4y expired

What this patent protects

C \Interwoen\NRPortbl\DCC\AAR\18720783_I.docx-4/16/2019 ABSTRACT The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.

USPTO Abstract

C \Interwoen\NRPortbl\DCC\AAR\18720783_I.docx-4/16/2019 ABSTRACT The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020250309B2
Jurisdiction
AU
Classification
—
Expires
2022-08-04
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.